Carotuximab

From WikiMD's Medical Encyclopedia

Revision as of 11:33, 10 February 2025 by Prab (talk | contribs) (CSV import)

Carotuximab
[[File:|frameless|220px|alt=|]]
INN
Drug class
Routes of administration
Pregnancy category
Bioavailability
Metabolism
Elimination half-life
Excretion
Legal status
CAS Number 1268714-50-6
PubChem
DrugBank
ChemSpider none
KEGG D11260


Carotuximab (INN<ref name=WHOList114>World Health Organization,

 International Nonproprietary Names for Pharmaceutical Substances (INN). Proposed INN: List 114, 
 WHO Drug Information, 
 2015,
 Vol. 29(Issue: 4),
 
 
 
 
 
 Full text,</ref>) (TRC-105) is a chimeric monoclonal antibody designed for the treatment of cancer.

This drug was developed by Tracon Pharmaceuticals Inc.<ref>Statement On A Nonproprietary Name Adopted By The USAN Council - Carotuximab, American Medical Association.</ref>

It is at Phase III trials for angiosarcoma.

References

<references/>

Stub icon
   This article is a monoclonal antibody–related stub. You can help WikiMD by expanding it!




Stub icon
   This article is a medical stub. You can help WikiMD by expanding it!
Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes


Ad. Transform your life with W8MD's

GLP-1 weight loss injections special from $29.99 with insurance

Advertise on WikiMD


WikiMD Medical Encyclopedia

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.